Pancreatic beta-cell loss and preservation in type 2 diabetes

Pancreatic beta-cell loss and preservation in type 2 diabetes Background : In most individuals, the need to respond to progressive states of insulin resistance is met by increasing insulin production. For insulin-resistant patients, however, the balance between insulin supply and demand may fail from the progressive loss of pancreatic beta-cell function, eventually leading to type 2 diabetes mellitus. Objective : The aim of this review was to discuss the current concepts underlying potential pancreatic beta-cell failure in the progression toward type 2 diabetes and therapies that may alter the process. Methods : Data included in this review were identified through a MEDLINE search for articles published from 1966 to April 2003. Search terms used were beta cell, diabetes, insulin resistance, obesity, cardiovascular disease, thiazolidinediones , and metformin . Results : Evidence of the progressive loss of beta-cell function may include altered conversion of proinsulin to insulin, changes in pulsed and oscillatory insulin secretion, and quantitative reductions in insulin release. Potential underlying mechanisms are glucose toxicity, lipotoxicity, poor tolerance of increased secretory demand, and a reduction in beta-cell mass. Conclusion : Current clinical management of type 2 diabetes is focused on treatment of the signs and symptoms of late-stage disease rather than addressing potential underlying causes, which may be amenable to currently available therapies, based on a broad understanding of existing data, practice experience, and rational speculation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Therapeutics Elsevier

Pancreatic beta-cell loss and preservation in type 2 diabetes

Clinical Therapeutics, Volume 25 – Jan 1, 2003

Loading next page...
 
/lp/elsevier/pancreatic-beta-cell-loss-and-preservation-in-type-2-diabetes-xCSrMxxYpB
Publisher
Elsevier
Copyright
Copyright © 2003 Elsevier Ltd
ISSN
0149-2918
D.O.I.
10.1016/S0149-2918(03)80241-2
Publisher site
See Article on Publisher Site

Abstract

Background : In most individuals, the need to respond to progressive states of insulin resistance is met by increasing insulin production. For insulin-resistant patients, however, the balance between insulin supply and demand may fail from the progressive loss of pancreatic beta-cell function, eventually leading to type 2 diabetes mellitus. Objective : The aim of this review was to discuss the current concepts underlying potential pancreatic beta-cell failure in the progression toward type 2 diabetes and therapies that may alter the process. Methods : Data included in this review were identified through a MEDLINE search for articles published from 1966 to April 2003. Search terms used were beta cell, diabetes, insulin resistance, obesity, cardiovascular disease, thiazolidinediones , and metformin . Results : Evidence of the progressive loss of beta-cell function may include altered conversion of proinsulin to insulin, changes in pulsed and oscillatory insulin secretion, and quantitative reductions in insulin release. Potential underlying mechanisms are glucose toxicity, lipotoxicity, poor tolerance of increased secretory demand, and a reduction in beta-cell mass. Conclusion : Current clinical management of type 2 diabetes is focused on treatment of the signs and symptoms of late-stage disease rather than addressing potential underlying causes, which may be amenable to currently available therapies, based on a broad understanding of existing data, practice experience, and rational speculation.

Journal

Clinical TherapeuticsElsevier

Published: Jan 1, 2003

References

  • Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
    Kern, P.A.; Ranganathan, S.; Li, C.
  • The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes
    Kahn, S.E.
  • Is insulin resistance the principal cause of type 2 diabetes?
    Gerich, J.E.
  • Early disturbances in insulin secretion in the development of type 2 diabetes mellitus
    van Haeften, T.W.
  • Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance
    Ward, W.K.; LaCava, E.C.; Paquette, T.L.
  • Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus
    Yoshioka, N.; Kuzuya, T.; Matsuda, A.
  • Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics
    Temple, R.C.; Clark, P.M.; Nagi, D.K.
  • Control of pulsatile insulin secretion in man
    Matthews, D.R.; Lang, D.A.; Burnett, M.A.; Turner, R.C.
  • Insulin secretion and clearance during low-dose graded glucose infusion
    Byrne, M.M.; Sturis, J.; Polonsky, K.S.
  • Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans
    Kahn, S.E.; Bergman, R.N.; Schwartz, M.W.
  • Adaptation of B and A cell function during prolonged glucose infusion in human subjects
    Ward, W.K.; Halter, J.B.; Beard, J.C.; Porte, D.
  • Longitudinal studies on the development of diabetes in individual Macaca nigra
    Howard, C.F.
  • Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a mouse model
    Hoppener, J.W.; Oosterwijk, C.; Nieuwenhuis, M.G.
  • Oophorectomy promotes islet amyloid formation in a transgenic mouse model of type II diabetes
    Kahn, S.E.; Andrikopoulos, S.; Verchere, C.B.
  • Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone
    Sreenan, S.; Sturis, J.; Pugh, W.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off